Changes in Estrogen Receptor (ER), Progesterone Receptor (PgR) and HER2/neu Status During Primary Systemic Chemotherapy in Breast Cancer

被引：0
|
作者：
Tozuka, K. [1 ]
Horiguchi, J. [1 ]
Takata, D. [1 ]
Rokutanda, N. [1 ]
Nagaoka, R. [1 ]
Tokiniwa, H. [1 ]
Kikuchi, M. [1 ]
Satou, A. [1 ]
Takeyoshi, I. [1 ]
机构：
[1] Gunma Univ Hosp, Maebashi, Gunma, Japan
来源：
EUROPEAN JOURNAL OF CANCER | 2012年 / 48卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S126 / S127
页数：2
相关论文
共 50 条
  • [1] Changes in estrogen receptor (ER), progesterone receptor (PR) and HER2/neu status with time: Discordance rates between primary and metastatic breast pathology samples
    Broom, R. J.
    Tang, P.
    Simmons, C.
    Bordeleau, L.
    O'Malley, F. P.
    Miller, N.
    Andrulis, I. L.
    Brenner, D. M.
    Clemons, M.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [2] Discordances in Estrogen Receptor Status, Progesterone Receptor Status, and HER2 Status Between Primary Breast Cancer and Metastasis
    Curtit, Elsa
    Nerich, Virginie
    Mansi, Laura
    Chaigneau, Loic
    Cals, Laurent
    Villanueva, Cristian
    Bazan, Fernando
    Montcuquet, Philippe
    Meneveau, Nathalie
    Perrin, Sophie
    Algros, Marie-Paule
    Pivot, Xavier
    ONCOLOGIST, 2013, 18 (06): : 667 - 674
  • [3] Is there an association between estrogen receptor and Her2/neu status in breast cancer?
    Hanna, W
    Kahn, HJ
    Szalai, JP
    MODERN PATHOLOGY, 2002, 15 (01) : 36A - 36A
  • [4] Is there an association between estrogen receptor and Her2/neu status in breast cancer?
    Hanna, W
    Kahn, HJ
    Szalai, JP
    LABORATORY INVESTIGATION, 2002, 82 (01) : 36A - 36A
  • [5] Assessment of estrogen receptor (ER), progesterone receptor (PR) and Her2/neu status in fine needle aspirates of metastatic breast carcinomas
    Cai, G.
    Monaco, S.
    Teot, L.
    HISTOPATHOLOGY, 2008, 53 : 83 - 83
  • [6] Breast Cancer Biomarkers Challenges in Routine Estrogen Receptor, Progesterone Receptor, and HER2/neu Evaluation
    Jorns, Julie M.
    ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE, 2019, 143 (12) : 1444 - 1449
  • [7] Changes in Estrogen Receptor, Progesterone Receptor and Her-2/neu Status with Time: Discordance Rates Between Primary and Metastatic Breast Cancer
    Broom, Reuben J.
    Tang, Patricia A.
    Simmons, Christine
    Bordeleau, Louise
    Mulligan, Anna Marie
    O'Malley, Frances P.
    Miller, Naomi
    Andrulis, Irene L.
    Brenner, Darren M.
    Clemons, Mark J.
    ANTICANCER RESEARCH, 2009, 29 (05) : 1557 - 1562
  • [8] The role of HER2/neu, estrogen, and progesterone receptor status in the risk and survival of breast cancer leptomeningeal metastasis
    Grewal, J.
    Groves, M. D.
    Bekele, B. N.
    Yung, W. A.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [9] MicroRNA signatures predict oestrogen receptor, progesterone receptor and HER2/neu receptor status in breast cancer
    Lowery, Aoife J.
    Miller, Nicola
    Devaney, Amanda
    McNeill, Roisin E.
    Davoren, Pamela A.
    Lemetre, Christophe
    Benes, Vladimir
    Schmidt, Sabine
    Blake, Jonathon
    Ball, Graham
    Kerin, Michael J.
    BREAST CANCER RESEARCH, 2009, 11 (03):
  • [10] Receptor status (ER, PgR and HER2) discordance between primary tumor and locoregional recurrence in breast cancer
    Zurrida, S.
    Montagna, E.
    Naninato, P.
    Colleoni, M.
    Goldhirsch, A.
    ANNALS OF ONCOLOGY, 2011, 22 (02) : 479 - U259
12345